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1046s 157 Expression of Hypoxia-Inducible Factors and of 
Vascular Endothelial Growth Factor in Infants With 
Congenital Cardiac Defect 
QingMa, Agnes Gorfach. Kathrin Schumacher, Jaime F. Vazquez-Jimenez, John Hess, 
Gdtz von Bernuth. Marie-Christine Seghaye, German Heart Center Munich, TUM, 
Munich, Germany 
Background: Hypoxia and mechanical stress could up-regulate mediators of angiogene- 
sis such as VEGF rn the myocardium of infants with congenital cardiac defect. This study 
was aimed to test this hypothesis. 
Methods: Expression of VEGF-mRNA was detected by RT-PCR in the right atrial- and 
ventricular myocardium of infants with a cyanotic cardiac defect (tetralogy of Fallot 
(TOF)) (n=7) or with an acyanotic cardiac defect (ventricular septum defect (VSD)) (n=7). 
Levels of VEGF, and of rts transcriptional activators HIF-la and HIF-2a were measured 
by Western blot and their localization in the myocardium by immunocytochemistry. Lev- 
els of the activators of HIF-la (phospho-Akt and MAP-kinases) were also measured by 
Western blot. 
Results: VEGF-mRNA was expressed in both atria1 and ventricular myocardium of all 
patients but VEGF levels tended to be higher in infants with TOF than in those with VSD 
(p=.O9). Levels of HIF-la and HIF-2a were also higher rn the former (pz.03, pz.06) as 
were levels of phospho-p38 and phospho-Akt (p=.O3; p=.OZ, respectively). In all patients, 
levels of HIF-la and VEGF correlated Inversely with preoperative arterial oxygen satura- 
tion (Spearman: -.64, p-z.02; -.76 p.z.004, respectively). HIF-la was present in the nuclei 
of cardiomyocytes. and HIF-2a also in endothelial cells and macrophages. VEGF was 
found in the cytoplasm of cardiomyccytes and endothelial cells. 
Conclusion: Our results suggest that in infants with congenital cardiac defect chronic 
hypoxemia leads to over-expression of HIF-la and HIF-2a via the Akt- and MAP-kinase 
p38 signaling pathways. This is responsible for increased VEGF synthesis in cardiomyo- 
cytes and myocardial endothelial cells, and could regulate myocardial remodeling in this 
age group. 
1046- 158 Superoxide Dismutase Reduces Reoxygenation- 
Induced Cardiopulmonary Dysfunction in the Immature 
Heart 
Jefferv M. Pearl, Connie J. Wagner, Jerri L. McNamara, Jodie Y. Duffy. Cincinnati 
Children’s Hospital Medical Center, Cincinnati, OH 
Background: Superoxide radicals and their interaction with nitric oxide (NO) during 
hypoxia and reoxygenation result in cellular damage and cardiac dysfunction. The 
hypothesis was that superoxide dismutase (SOD), a superoxide radical scavenger, could 
improve cardiac recovery after reoxygenation in a neonatal piglet model incorporating 
cardiopulmonary bypass (CPB). 
Methods: Neonatal piglets underwent 90 mm of hypoxia followed by 1 hr raoxygenation 
on CPB. Animals were maintained for 2 hr after reoxygenation. One group (n=6. SOD) 
received 15,000 unitsikgihr of SOD during hypoxia and reoxygenation. Control animals 
received saline (n=lO). Nitric oxide levels were measured in exhaled air with chemilumi- 
nescent detecbon and systemically with in viva NO-permeable probes. Peroxynitrite pro- 
duction was estimated by sconng intensity and lkxalization of nitrotyrosine 
immunohistochemical staining in cardiac tissue. 
Results: SOD administration reduced cardiac dysfunction associated with reoxygenation 
injury Control LV +dP/dt decreased from a baseline mean of 1242 +I- 101 to 648 +/- 80 
mm Hg/sec at 2 hr after reoxygenation (P<.O5). SOD animals maintained ventricular sys- 
tolic function at 944 +/- 30 mm Hg/sec after reoxygenatron (Pc.05 vs controls). RV +dP/dt 
was also malntained in SOD animals at 520 +/- 31 compared with controls at 281 +/- 11 
mm Hg/sec (Pc.05). Oxygen delivery 2 hr after reoxygenation was preserved in SOD ani- 
mak (718 +I- 82 ml&m) compared with controls (452 +I- 62 mUmin; Pc.05). The SOD 
group had higher systemic and exhaled NO levels than controls after hypoxia and 2 hr 
after reoxygenation (Pc.05). Nitrotyrosine immunohistochemical scores from LV tissue 
collected 2 hr after reoxygenation were lower in animals receiving SOD (1.4 +I- .8) than 
controls (3.7 +//- .8; P<.O5). 
Conclusions: Administration of a superoxide scavenger during hypoxia and reoxygen- 
ation reduced cardiac dysfunction assorrated with reoxygenatlon injury and preserved 
systemic NO levels. Recovery of cardiac function might partially result from reducing the 
interaction of superoxide and NO to form peroxynitrite, a cytotoxic oxidant, as well as 
preserving beneficial NO levels. 
1046-l 59 Left Atrioventricular Valve Function Following Repair of 
Atrioventricular Septal Defects: A 22-Year Experience 
Christooher 6. Mahnke. Janine E. Janosky, Frank A. Pigula. Ralph 0. Spewers, Prapti 
Kanani, Children’s Hospital of Pittsburgh, Pittsburgh, PA 
Backwound: Left atrioventncular valve (LAVV) function is crucral for Iona-term clinical 
success following repair of atrioventricular septal defects (AVSD). We reviewed our 
exPerience with AVSD reoair to identifv aredictors of ooor oost-ooerative LAVV function. , 
Methods: A retrospective chart review was performed on all patients who underwent 
biventricular repair of complete and partial AVSD at our institution from 1980-2001. Ana- 
tomic, hemodynamic, and surgical vanables were correlated wrth post-operative LAVV 
function and repeat LAVV surgery 
Results: Two-hundred seventy patients underwent AVSD repair during the study period. 
There were 24 pen-operative deaths. Long-term outcome data was available for 220 
patients (109 complete AVSD, 111 pamal AVSD). Twenty-seven survivors reqwed 
repeat LAVV surgery (12.3%; 24 for LAVV regurgitation) with no deaths. Absence of 
Down syndrome, abnormal papillary muscles, and moderate/severe preoperative or 
Immediate post-operative LAVV regurgitation were each associated with repeat LAVV 
surgery (p<O.O5). In addihon, repeat LAVV surgery was more common in patients with 
partral AVSD (p=O.O77) and unbalanced AVSD with small LV (p=O.O64). In the 24 
patlents requiring repeat surgery for LAVV regurgitation, repair of the LAVV was accom- 
plished in 14 (58%). Successful LAVV repair (versus replacement) was more common in 
patients with Down syndrome (Down syndrome 7/E, non-Down 7/16; p=O.OE). For most 
patients, the degree of LAVV regurgitation remained stable over time. Progression to 
severe LAVV regurgitation was rare (24 pahents; 1.4% per pt yr) and usually developed 
within the first 5 post-operative years (19/24, 79%). LAVV stenosis occurred In 3.6% of 
survivors, and was associated with unbalanced AVSD and papillary muscle abnormali- 
ties. 
Conclusion: Following AVSD repair, LAVV regurgitation requiring repeat surgical inter- 
vention was associated with the absence of Down syndrome, abnormal papillary mus- 
cles, partial AVSD, unbalanced AVSD with small LV, and moderate/severe pre-operative 
or immediate post-operative LAVV regurgitation. Progressron to severe LAVV regurgita- 
tion over time was rare. 
1046-l 60 Anomalous Origin of the Left Coronary Artery From the 
Pulmonary Trunk: A 25Year Single institution Outcome 
Study Following Surgical Restoration of Dual Coronary 
Antegrade Flows 
Subash C. Reddy, Gerard A. Boyle, Steven A. Webber, Sang C. Park, Lee B. Beerman 
William H. Neches, Children’s Hospital of Pittsburgh, Pittsburgh, PA 
Background: Our group demonstrated surgical feasrbility of coronary translocation in 
patients (pts) with anomalous origin of left coronary artery from pulmonary trunk 
(ALCAPA). We report our surgical results and long-term follow-up in these pts. Methods: 
Records of pts with ALCAPA and surgery between 1976-2000 were reviewed. Symp- 
toms, left ventricular (LV) dimensions, mitral regurgitation (MR), hemodynamics, and 
type of repair were correlated with the immediate outcome (alive vs. dead). In the survi- 
vors we reviewed time course of improvement in LV function and MR, w-operations. 
exercise capacity, residual ischemia. clinical arrhythmias, sudden cardiac death, and 
length of follow-up. Results: There were 23 pts with ALCAPA and surgery. Mean age at 
presentation was 9.7 months. Presenting features were congestive cardiac failure in 16, 
MR in 16 and dilated LV with reduced shortening fraction in 20. Operations included cor- 
onary translocation in 19, and Tekeuchi in 4. There were 3 postoperative deaths. 
Increased LV end diastolic dimension (LVEDD) and severe MR predicted an adverse 
outcome (P=cO.O5). The 20 survivors were followed for a mean of 91 (13 to 229) months. 
On serial echo evaluations the mean time period for reduction rn the LVEDD and 
decrease in MR was 3 months, and for recovery of LV systolic function was 6 months. 
There were no resting LV regional wall motion abnormalities or aneurysms. Eleven pts 
demonstrated normal exercrse capactty and no Inducible lschemia on exercrse testing. 
There ware no clinically srgnificant arrhythmias or sudden deaths, and all survivors were 
in NYHA functional class I at latest follow-up. All pts with Tekeuchi repair underwent 
reoperation between 2-14 years for supravalvular stensosis. Conclusions There was 
an excellent outcome following surgery (87% survivors). Increased LVEDD and severe 
MR predicted adverse outcome. There was early recovery in LV function. All had good 
functional capacity and no residual ischemia. arrhythmias, or sudden deaths at long-term 
follow-up. Direct coronary artery translocation was superror to Tekeuchi repair. 
1046-161 Oxidant Stress and Pulmonary Hypertension in 
Congenital Heart Surgery 
Karrie L. Dver, Rick Barr, Marshall Summar. Gary Cunningham, Thomas P. Doyle, 
Thomas P. Graham, Brian W. Christman, Vanderbilt Universrty Medical Center, 
Nashville, TN 
Background: Pulmonary hypertension (PHT) is a potentially severe complication of con- 
genital heart surgery. Cardiopulmonary bypass (CPB) may impair endothelial function 
through ischemia reperfusion injury, which IS mediated by oxygen radical activity. Iso- 
prostanes are chemically stable products of arachadomc acid generated from free radical 
activity and thus serve as markers of oxidant stress. Pulmonary vascular tone is regu- 
lated by endothelial secretion of vasoactfve substances such as nitric oxide; plasma nitric 
oxrde (NO) metabolites therefore reflect endothelial functron. In this study, isoprostane 
excretion is measured among infants undergoing CPB and correlated with clinical mea- 
sures of pulmonary hypertension as well as plasma NO metabolites. 
Methods: lsoprostane levels were measured in 41 infants preop. immediately postop, 12 
, 24 and 48 hours postop. lsoprostane metabolites were quantified using stable isotope 
diluation methods in conjunction with gas chromatography/mass spectrometry and were 
normalized to creatinine. NO metabolites were measured in plasma collected at the 
same time points. Pulmonary artery (PA) pressures were measured drrectly in a subset 
of patients with indwelling PA lines. PHT was defined by mean PA pressure greater than 
20mm Hg or greater than 50% systemic or the clinical requirement for NO. 
Results: Peak isoprostane excretion occured immediately postop and returned to base- 
line by 48 hours. Mean isoprostane levels among all 41 patients increased by greater 
then 200% from pra to post-CPB (2.9 cl-l.9 nglmg to 8.7+/-5.7ng/mg, p=.OOOl). Among 
patients with PHT (n=15), mean rsoprostane excretion increased by over 300% from pm 
to postop (2.5 +I-2.2 nglmg to 8.0 +/-7.6 nglmg. p=.Ol). Concurrently, NO metabolites 
decreased from 7.4 +/-7.6 mcg to 2.4 +/- 1.4 mcg from pre to postop among all 41 
patients (p=.OOOS) 
Conclusions: Oxidant stress IS increased following CPB among infants with congenltal 
heart disease. Patients with PHT demonstrated a more prominent increase in isopros- 
tane excretion. The concurrent decrease in NO metabolites with peak isoprostane excra- 
tion suggests that oxidant stress may alter endothelial production of endogenous 
vasodilators. 
